Cargando…
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
Adoptive cell therapy (ACT) with tumor-specific T cells has been shown to mediate durable cancer regression. Tumor-specific T cells are also the basis of other therapies, notably cancer vaccines. The main target of tumor-specific T cells are neoantigens resulting from mutations in self-antigens over...
Autores principales: | Mariuzza, Roy A., Wu, Daichao, Pierce, Brian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693334/ https://www.ncbi.nlm.nih.gov/pubmed/38045695 http://dx.doi.org/10.3389/fimmu.2023.1303304 |
Ejemplares similares
-
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
por: Wu, Daichao, et al.
Publicado: (2020) -
T cell receptors employ diverse strategies to target a p53 cancer neoantigen
por: Wu, Daichao, et al.
Publicado: (2022) -
Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019) -
NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
por: Xia, Jiaqi, et al.
Publicado: (2021) -
Structural Basis for Recognition of Cellular and Viral Ligands by NK Cell Receptors
por: Li, Yili, et al.
Publicado: (2014)